XML 136 R128.htm IDEA: XBRL DOCUMENT v3.22.0.1
Restatement of Previously Issued Condensed Financial Statements - Statement of Cash Flows (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2021
Jun. 30, 2021
Mar. 31, 2021
Sep. 30, 2020
Jun. 30, 2020
Mar. 31, 2020
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
Dec. 31, 2019
Error Corrections and Prior Period Adjustments Restatement [Line Items]                    
Net loss $ 28,424 $ (131,567) $ (55,951) $ (181,986) $ (25,281) $ (129,633) $ (159,094) $ (336,900)    
Depreciation and amortization 130,683     68,614     392,513 176,200    
Deferred income tax benefit             (11,076) (7,420)    
Share-based Compensation             3,054 26,344    
Fair Value Adjustment of Warrants (83,013)     144,753     (113,207) 224,175    
Increase (Decrease) in Deferred Charges             9,050 3,140    
Other Non cash Income (Expense) excluding Gain on sale of line of business               3,902    
Other Noncash Income (Expense)             3,565 (3,902)    
Increase (Decrease) in Accounts Receivable             114,038 129,398    
Increase (Decrease) in Prepaid Expense             (887) (13,335)    
Restricted cash 1,857,657     567     1,857,657 567 $ 14,678 $ 9
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 4,337,537     601,642     4,337,537 601,642 272,408 76,139
Cash paid for interest             97,401 61,796    
Cash paid for income tax             22,387 20,147    
Capital expenditures included in accounts payable             6,612 922    
Mark to Market Loss on Contingent Shares             25,085 (30,839)    
Increase (Decrease) in Other Noncurrent Assets             60,749 62,818    
Accounts payable             13,550 (8,394)    
Accrued expenses and other current liabilities             90,439 (65,062)    
Deferred revenues             (116,312) (93,926)    
Operating lease right of use assets             16,838 5,826    
Operating lease liabilities             (37,362) (6,611)    
Other liabilities             2,905 2,077    
Net Cash Provided by (Used in) Operating Activities             305,515 128,022    
Capital expenditures             (86,197) (78,597)    
Payments to Acquire Businesses, Net of Cash Acquired             (14,314) (885,323)    
Proceeds from sale of product line, net of restricted cash             0 3,751    
Net Cash Provided by (Used in) Investing Activities             (100,511) (966,151)    
Principal payments on term loan             (21,450) (9,450)    
Repayments of Long-term Lines of Credit             0 (65,000)    
Payments of Debt Issuance Costs             (7,471) (5,267)    
Payment for Contingent Consideration Liability, Financing Activities             0 (4,115)    
Proceeds from issuance of debt               360,000    
Proceeds from issuance of ordinary shares             728,080 843,752    
Proceeds from warrant exercises             0 277,526    
Proceeds from stock options exercised             17,250 1,307    
Payments related to tax withholding for stock-based compensation             (21,455) (28,674)    
Net cash provided by financing activities             3,864,985 1,370,079    
Effects of exchange rates             (4,860) (6,447)    
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect             4,065,129 525,503    
Cash and cash equivalents 2,479,880     601,075     2,479,880 601,075 257,730 76,130
Bad debt expense             6,832 1,830    
Gain (Loss) on Disposition of Business             0 (1,052)    
Noncash Impairment, Leases 757     110     50,979 4,880    
Acquisition of intangible assets             0 (5,982)    
Gain (Loss) on Foreign Currency Forward Contracts             4,026 (2,903)    
Previously Reported                    
Error Corrections and Prior Period Adjustments Restatement [Line Items]                    
Net loss 23,312     (37,233)     (82,852) (112,725)    
Depreciation and amortization             392,513 176,200    
Deferred income tax benefit             (11,084) (7,420)    
Share-based Compensation             36,944 26,344    
Fair Value Adjustment of Warrants (83,013)     0     (113,207) 0    
Increase (Decrease) in Deferred Charges             9,050 3,140    
Other Noncash Income (Expense)             3,565 (3,902)    
Increase (Decrease) in Accounts Receivable             114,038 129,398    
Increase (Decrease) in Prepaid Expense             (887) (13,335)    
Restricted cash 1,854,257     567     1,854,257 567 11,278 9
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 4,334,137     601,642     4,334,137 601,642 269,008 76,139
Cash paid for interest             97,401 61,796    
Cash paid for income tax             22,387 20,147    
Capital expenditures included in accounts payable             6,612 922    
Mark to Market Loss on Contingent Shares             34,503 (30,839)    
Increase (Decrease) in Other Noncurrent Assets             60,749 62,818    
Accounts payable             13,550 (8,394)    
Accrued expenses and other current liabilities             (14,208)      
Deferred revenues             (116,312) (93,926)    
Operating lease right of use assets             16,838 5,826    
Operating lease liabilities             (37,362) (6,611)    
Other liabilities             (2,407) 2,077    
Net Cash Provided by (Used in) Operating Activities             305,515 128,022    
Capital expenditures             (86,197) (78,597)    
Payments to Acquire Businesses, Net of Cash Acquired             (14,314) (885,323)    
Proceeds from sale of product line, net of restricted cash               3,751    
Net Cash Provided by (Used in) Investing Activities             (100,511) (966,151)    
Principal payments on term loan             (21,450) (9,450)    
Repayments of Long-term Lines of Credit             0 (65,000)    
Payments of Debt Issuance Costs             (7,471) (5,267)    
Payment for Contingent Consideration Liability, Financing Activities             0 (4,115)    
Proceeds from issuance of debt               360,000    
Proceeds from issuance of ordinary shares             728,080 843,752    
Proceeds from warrant exercises             0      
Proceeds from stock options exercised             17,250      
Payments related to tax withholding for stock-based compensation             (21,455) (28,674)    
Net cash provided by financing activities             3,864,985 1,370,079    
Effects of exchange rates             (4,860) (6,447)    
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect             4,065,129 525,503    
Cash and cash equivalents 2,479,880     601,075     2,479,880 601,075 257,730 $ 76,130
Bad debt expense             6,832 1,830    
Gain (Loss) on Disposition of Business               (1,052)    
Noncash Impairment, Leases             60,232 4,880    
Acquisition of intangible assets               (5,982)    
Gain (Loss) on Foreign Currency Forward Contracts             4,026 2,903    
Revision of Prior Period, Error Correction, Adjustment                    
Error Corrections and Prior Period Adjustments Restatement [Line Items]                    
Net loss 5,112     (144,753)     (76,242) (224,175)    
Depreciation and amortization             0      
Deferred income tax benefit             8      
Share-based Compensation             (33,890)      
Fair Value Adjustment of Warrants 0     $ 144,753     0 $ 224,175    
Increase (Decrease) in Deferred Charges             0      
Other Noncash Income (Expense)             0      
Increase (Decrease) in Accounts Receivable             0      
Increase (Decrease) in Prepaid Expense             0      
Restricted cash 3,400           3,400   3,400  
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3,400           3,400   3,400  
Cash paid for interest             0      
Cash paid for income tax             0      
Capital expenditures included in accounts payable             0      
Mark to Market Loss on Contingent Shares             (9,418)      
Increase (Decrease) in Other Noncurrent Assets             0      
Accounts payable             0      
Accrued expenses and other current liabilities             104,647      
Deferred revenues             0      
Operating lease right of use assets             0      
Operating lease liabilities             0      
Other liabilities             5,312      
Net Cash Provided by (Used in) Operating Activities             0      
Capital expenditures             0      
Payments to Acquire Businesses, Net of Cash Acquired             0      
Net Cash Provided by (Used in) Investing Activities             0      
Principal payments on term loan             0      
Repayments of Long-term Lines of Credit             0      
Payments of Debt Issuance Costs             0      
Payment for Contingent Consideration Liability, Financing Activities             0      
Proceeds from issuance of ordinary shares             0      
Proceeds from warrant exercises             0      
Proceeds from stock options exercised             0      
Payments related to tax withholding for stock-based compensation             0      
Net cash provided by financing activities             0      
Effects of exchange rates             0      
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect             0      
Cash and cash equivalents $ 0           0   $ 0  
Bad debt expense             0      
Noncash Impairment, Leases             (9,253)      
Gain (Loss) on Foreign Currency Forward Contracts             $ 0